1. 144. MSG-15: Pharmacokinetic (PK), Adverse Events (AEs), and Tolerability Data from an Open Label Randomized Clinical Trial (RCT) Comparing Oral Suba-itraconazole (SUBA-ITC) to Conventional Itraconazole (C-ITC) for Treatment of Endemic Mycosis (EM). (31st December 2020) Authors: Pappas, Peter G; Spec, Andrej; Miceli, Marisa H; Proia, Laurie; Arauz, Ana Belen; Hayes, Justin; Peinhardt, Alisa; McMullen, Rachel; Moore, Mary K; McGwin, Gerald; Thompson III, George R Journal: Open forum infectious diseases Issue: Volume 7:Number 1(2020) Supplement Page Start: S202 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗